TY - JOUR
T1 - Proteínas terapêuticas
T2 - Presente e perspectivas futuras
AU - Ferreira, João Paulo M.
PY - 1999/7
Y1 - 1999/7
N2 - The number of products for human therapeutics and diagnostics based on proteins already on the market is large. For the next few years, many new ones are expected to be launched. This growth is due, among other developments, to advances on recombinant DNA technology, and on monoclonal antibodies production. All professionals in the pharmaceutical sector - from industry, trade, to health services practice-, need to be familiar with those products, as they have specificities concerning their production, use, and business management. This text is an overview of these issues, for different groups of protein-based biopharmaceuticals.
AB - The number of products for human therapeutics and diagnostics based on proteins already on the market is large. For the next few years, many new ones are expected to be launched. This growth is due, among other developments, to advances on recombinant DNA technology, and on monoclonal antibodies production. All professionals in the pharmaceutical sector - from industry, trade, to health services practice-, need to be familiar with those products, as they have specificities concerning their production, use, and business management. This text is an overview of these issues, for different groups of protein-based biopharmaceuticals.
KW - Biopharmaceuticals
KW - Enzymes for diagnostics
KW - Immunodiagnostics
KW - Markets
KW - Therapeutic proteins
KW - Vaccines
UR - http://www.scopus.com/inward/record.url?scp=0040964486&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:0040964486
SN - 0484-811X
VL - 49
SP - 131
EP - 140
JO - Revista Portuguesa de Farmacia
JF - Revista Portuguesa de Farmacia
IS - 3
ER -